• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

诊断相关分组“所有支付方”医院支付与医学疾病。医学非并发症情况分层诊断相关分组中的财务风险与医院成本。

Diagnosis related group 'all payor' hospital payment and medical diseases. Financial risk and hospital cost in medical noncomplicating condition-stratified diagnosis related groups.

作者信息

Muñoz E, Goldstein J, Benacquista T, Mulloy K, Wise L

机构信息

Department of Surgery, Long Island Jewish Medical Center, New Hyde Park, NY 11042.

出版信息

Arch Intern Med. 1989 Feb;149(2):417-20. doi: 10.1001/archinte.1989.00390020117025.

DOI:10.1001/archinte.1989.00390020117025
PMID:2492795
Abstract

There are many health policy issues related to diagnosis-related group (DRG) hospital payment. Previous work by our group had suggested that some DRGs did not adequately comorbidities. Despite recommendations by federal advisory committees, the secretary of Health and Human Services has proposed no major changes to DRGs along these lines. We analyze resource consumption in any of the 88 non-complicating condition (CC)-stratified medical DRGs using the DRG prospective "all payor system" in effect at our hospital. Analysis of 12,340 medical patients by payor (Medicare, Medicaid, Blue Cross, and commercial insurance) in these non-CC-stratified medical DRGs for a three-year period demonstrated that patients with more CCs per DRG for each payor generated higher total hospital costs, a longer hospital length of stay, a greater percentage of procedures per patient, higher financial risk under DRG payment, and a higher mortality, compared with patients in these same DRGs with fewer CCs. These findings suggest that new prospective DRG all payor systems may be inequitable to certain groups of patients or types of hospitals vis-à-vis the non-CC-stratified medical DRGs. Health policy leaders should be encouraged to stratify many medical DRGs by the numbers and types of CCs to more equitably reimburse hospitals under DRG all payor systems.

摘要

有许多与诊断相关分组(DRG)医院支付相关的卫生政策问题。我们团队之前的研究表明,一些DRG未能充分考虑合并症情况。尽管联邦咨询委员会提出了建议,但卫生与公众服务部部长并未提议对DRG进行此类重大变革。我们使用我院现行的DRG前瞻性“全付费方系统”,分析了88个无并发症情况(CC)分层的医疗DRG中任何一个的资源消耗情况。在三年期间,对这些非CC分层医疗DRG中按付费方(医疗保险、医疗补助、蓝十字和商业保险)分类的12340名内科患者进行分析,结果表明,与同一DRG中合并症较少的患者相比,每个付费方每个DRG中合并症较多的患者产生的医院总成本更高、住院时间更长、每位患者的手术比例更高、DRG支付下的财务风险更高且死亡率更高。这些发现表明,相对于非CC分层的医疗DRG而言,新的前瞻性DRG全付费方系统可能对某些患者群体或医院类型不公平。应鼓励卫生政策领导人根据合并症的数量和类型对许多医疗DRG进行分层,以便在DRG全付费方系统下更公平地补偿医院。

相似文献

1
Diagnosis related group 'all payor' hospital payment and medical diseases. Financial risk and hospital cost in medical noncomplicating condition-stratified diagnosis related groups.诊断相关分组“所有支付方”医院支付与医学疾病。医学非并发症情况分层诊断相关分组中的财务风险与医院成本。
Arch Intern Med. 1989 Feb;149(2):417-20. doi: 10.1001/archinte.1989.00390020117025.
2
DRG prospective, "all payor systems," financial risk, and hospital cost in pulmonary medicine non CC stratified DRGs.肺科非复杂并发症分层诊断相关分组中的诊断相关分组前瞻性、“所有支付方系统”、财务风险和医院成本
Chest. 1988 Oct;94(4):855-61. doi: 10.1378/chest.94.4.855.
3
Financial risk and hospital cost in stratified, peripheral vascular surgical DRGs without complications and comorbidities.无并发症和合并症的分层外周血管外科诊断相关分组中的财务风险和医院成本
Ann Vasc Surg. 1989 Apr;3(2):170-6. doi: 10.1016/S0890-5096(06)62012-8.
4
Financial risk, hospital cost, and complications and comorbidities (CCs) in the non-CC-stratified pulmonary medicine diagnostic-related group Medicare hospital payment system.非并发症和合并症分层的肺病诊断相关分组医疗保险医院支付系统中的财务风险、医院成本以及并发症和合并症
Am Rev Respir Dis. 1988 May;137(5):998-1001. doi: 10.1164/ajrccm/137.5.998.
5
The equity of diagnostic related group "All Payor" hospital payment and gynecology diagnostic related groups.诊断相关分组“所有支付方”医院支付的公平性与妇科诊断相关分组
Obstet Gynecol. 1989 Dec;74(6):831-7.
6
Pediatric patients, DRG hospital payment, and comorbidities.儿科患者、疾病诊断相关分组(DRG)医院付费与共病情况
J Pediatr. 1989 Oct;115(4):545-8. doi: 10.1016/s0022-3476(89)80278-1.
7
Financial risk, hospital cost, complications and comorbidities (CCc) in non-CC stratified urology diagnostic related groups.非CC分层泌尿外科诊断相关组中的财务风险、医院成本、并发症和合并症(CCc)
Urology. 1988 Oct;32(4):380-4. doi: 10.1016/0090-4295(88)90251-8.
8
Surgonomics as a health care financing policy for hospitalized surgical patients.外科经济学作为一种针对住院手术患者的医疗保健融资政策。
Surg Gynecol Obstet. 1989 May;168(5):421-5.
9
Financial risk, hospital cost, complications, and comorbidities in surgical noncomplication- and noncomorbidity-stratified diagnostic related groups.手术无并发症和无合并症分层诊断相关组中的财务风险、医院成本、并发症及合并症
Ann Surg. 1988 Mar;207(3):305-9. doi: 10.1097/00000658-198803000-00013.
10
Health care financing policy for hospitalized rheumatology patients.住院风湿病患者的医疗保健融资政策。
J Rheumatol. 1989 Jul;16(7):885-9.

引用本文的文献

1
Prognostic Significance of Preoperative Circulating Monocyte Count in Patients With Breast Cancer: Based on a Large Cohort Study.乳腺癌患者术前循环单核细胞计数的预后意义:基于一项大型队列研究
Medicine (Baltimore). 2015 Dec;94(49):e2266. doi: 10.1097/MD.0000000000002266.